Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
≥ 32 33 32 33 O
1,800 34 39 34 39 B-lower_bound
cells 40 45 40 45 I-lower_bound
/ 45 46 45 46 I-lower_bound
mm^3 46 50 46 50 I-lower_bound

Acquired 0 8 51 59 B-chronic_disease
immune 9 15 60 66 I-chronic_disease
deficiency 16 26 67 77 I-chronic_disease
syndrome 27 35 78 86 I-chronic_disease
( 36 37 87 88 I-chronic_disease
AIDS 37 41 88 92 I-chronic_disease
) 41 42 92 93 I-chronic_disease
based 43 48 94 99 O
upon 49 53 100 104 O
current 54 61 105 112 O
Centers 62 69 113 120 O
for 70 73 121 124 O
Disease 74 81 125 132 O
Control 82 89 133 140 O
( 90 91 141 142 O
CDC 91 94 142 145 O
) 94 95 145 146 O
definition 96 106 147 157 O
( 107 108 158 159 O
HIV 108 111 159 162 B-chronic_disease
testing 112 119 163 170 O
is 120 122 171 173 O
not 123 126 174 177 O
required 127 135 178 186 O
for 136 139 187 190 O
entry 140 145 191 196 O
into 146 150 197 201 O
this 151 155 202 206 O
protocol 156 164 207 215 O
) 164 165 215 216 O

Acute 0 5 217 222 B-chronic_disease
bacterial 6 15 223 232 I-chronic_disease
or 16 18 233 235 O
fungal 19 25 236 242 B-chronic_disease
infection 26 35 243 252 I-chronic_disease
requiring 36 45 253 262 O
intravenous 46 57 263 274 B-treatment
antibiotics 58 69 275 286 I-treatment
at 70 72 287 289 O
the 73 76 290 293 O
time 77 81 294 298 O
of 82 84 299 301 O
registration 85 97 302 314 O

All 0 3 315 318 O
patients 4 12 319 327 O
must 13 17 328 332 O
have 18 22 333 337 O
a 23 24 338 339 O
Medical 25 32 340 347 B-treatment
Oncology 33 41 348 356 I-treatment
evaluation 42 52 357 367 O
within 53 59 368 374 O
4 60 61 375 376 B-upper_bound
weeks 62 67 377 382 I-upper_bound
prior 68 73 383 388 I-upper_bound
to 74 76 389 391 O
registration 77 89 392 404 O

Aspartate 0 9 405 414 B-clinical_variable
aminotransferase 10 26 415 431 I-clinical_variable
( 27 28 432 433 I-clinical_variable
AST 28 31 433 436 I-clinical_variable
) 31 32 436 437 I-clinical_variable
or 33 35 438 440 O
alanine 36 43 441 448 B-clinical_variable
aminotransferase 44 60 449 465 I-clinical_variable
( 61 62 466 467 I-clinical_variable
ALT 62 65 467 470 I-clinical_variable
) 65 66 470 471 I-clinical_variable
< 67 68 472 473 O
3 69 70 474 475 B-upper_bound
x 71 72 476 477 I-upper_bound
the 73 76 478 481 I-upper_bound
institutional 77 90 482 495 I-upper_bound
ULN 91 94 496 499 I-upper_bound

Hemoglobin 0 10 500 510 B-clinical_variable
≥ 11 12 511 512 O
8.0 13 16 513 516 B-lower_bound
g 17 18 517 518 I-lower_bound
/ 18 19 518 519 I-lower_bound
dL 19 21 519 521 I-lower_bound
( 22 23 522 523 O
the 23 26 523 526 O
use 27 30 527 530 O
of 31 33 531 533 O
transfusion 34 45 534 545 B-treatment
or 46 48 546 548 O
other 49 54 549 554 O
intervention 55 67 555 567 O
to 68 70 568 570 O
achieve 71 78 571 578 O
hemoglobin 79 89 579 589 B-clinical_variable
≥ 90 91 590 591 O
8.0 92 95 592 595 O
g 96 97 596 597 O
/ 97 98 597 598 O
dL 98 100 598 600 O
is 101 103 601 603 O
acceptable 104 114 604 614 O
) 114 115 614 615 O

High 0 4 616 620 B-clinical_variable
- 4 5 620 621 I-clinical_variable
grade 5 10 621 626 I-clinical_variable
acinic 11 17 627 633 I-clinical_variable
cell 18 22 634 638 I-clinical_variable
carcinoma 23 32 639 648 I-clinical_variable
or 33 35 649 651 I-clinical_variable
high 36 40 652 656 I-clinical_variable
- 40 41 656 657 I-clinical_variable
grade 41 46 657 662 I-clinical_variable
( 47 48 663 664 O
> 48 49 664 665 O
30 49 51 665 667 B-lower_bound
% 51 52 667 668 I-lower_bound
solid 53 58 669 674 O
component 59 68 675 684 O
) 68 69 684 685 O
adenoid 70 77 686 693 B-cancer
cystic 78 84 694 700 I-cancer
carcinoma 85 94 701 710 I-cancer

History 0 7 711 718 O
/ 7 8 718 719 O
physical 8 16 719 727 B-treatment
examination 17 28 728 739 I-treatment
within 29 35 740 746 O
8 36 37 747 748 B-upper_bound
weeks 38 43 749 754 I-upper_bound
prior 44 49 755 760 I-upper_bound
to 50 52 761 763 O
registration 53 65 764 776 O

Intermediate 0 12 777 789 O
- 12 13 789 790 O
grade 13 18 790 795 O
adenocarcinoma 19 33 796 810 B-cancer
or 34 36 811 813 O
intermediate 37 49 814 826 O
- 49 50 826 827 O
grade 50 55 827 832 O
mucoepidermoid 56 70 833 847 B-cancer
carcinoma 71 80 848 857 I-cancer

Negative 0 8 858 866 B-pregnancy
serum 9 14 867 872 I-pregnancy
pregnancy 15 24 873 882 I-pregnancy
test 25 29 883 887 O
within 30 36 888 894 O
2 37 38 895 896 B-upper_bound
weeks 39 44 897 902 I-upper_bound
prior 45 50 903 908 I-upper_bound
to 51 53 909 911 O
registration 54 66 912 924 O
for 67 70 925 928 O
women 71 76 929 934 B-gender
of 77 79 935 937 O
childbearing 80 92 938 950 O
potential 93 102 951 960 O

No 0 2 961 963 O
concurrent 3 13 964 974 O
erythropoiesis 14 28 975 989 B-treatment
- 28 29 989 990 I-treatment
stimulating 29 40 990 1001 I-treatment
agents 41 47 1002 1008 I-treatment

No 0 2 1009 1011 O
concurrent 3 13 1012 1022 O
hematopoietic 14 27 1023 1036 B-treatment
growth 28 34 1037 1043 I-treatment
factors 35 42 1044 1051 I-treatment
( 43 44 1052 1053 O
e.g. 44 48 1053 1057 O
, 48 49 1057 1058 O
G 50 51 1059 1060 B-treatment
- 51 52 1060 1061 I-treatment
CSF 52 55 1061 1064 I-treatment
or 56 58 1065 1067 O
pegfilgrastim 59 72 1068 1081 B-treatment
) 72 73 1081 1082 O
during 74 80 1083 1089 O
radiotherapy 81 93 1090 1102 B-treatment

No 0 2 1103 1105 O
patients 3 11 1106 1114 O
with 12 16 1115 1119 O
residual 17 25 1120 1128 B-chronic_disease
macroscopic 26 37 1129 1140 I-chronic_disease
disease 38 45 1141 1148 I-chronic_disease
after 46 51 1149 1154 O
surgery 52 59 1155 1162 B-treatment

No 0 2 1163 1165 O
prior 3 8 1166 1171 O
invasive 9 17 1172 1180 B-cancer
malignancy 18 28 1181 1191 I-cancer
( 29 30 1192 1193 O
except 30 36 1193 1199 O
non 37 40 1200 1203 B-cancer
- 40 41 1203 1204 I-cancer
melanomatous 41 53 1204 1216 I-cancer
skin 54 58 1217 1221 I-cancer
cancer 59 65 1222 1228 I-cancer
) 65 66 1228 1229 O
unless 67 73 1230 1236 O
disease 74 81 1237 1244 O
free 82 86 1245 1249 O
for 87 90 1250 1253 O
a 91 92 1254 1255 O
minimum 93 100 1256 1263 O
of 101 103 1264 1266 O
3 104 105 1267 1268 B-lower_bound
years 106 111 1269 1274 I-lower_bound
( 112 113 1275 1276 O
for 113 116 1276 1279 O
example 117 124 1280 1287 O
, 124 125 1287 1288 O
carcinoma 126 135 1289 1298 B-cancer
in 136 138 1299 1301 I-cancer
situ 139 143 1302 1306 I-cancer
of 144 146 1307 1309 I-cancer
the 147 150 1310 1313 I-cancer
breast 151 157 1314 1320 I-cancer
, 157 158 1320 1321 O
oral 159 163 1322 1326 B-cancer
cavity 164 170 1327 1333 I-cancer
, 170 171 1333 1334 O
or 172 174 1335 1337 O
cervix 175 181 1338 1344 B-cancer
are 182 185 1345 1348 O
all 186 189 1349 1352 O
permissible 190 201 1353 1364 O
) 201 202 1364 1365 O

No 0 2 1366 1368 O
prior 3 8 1369 1374 B-treatment
organ 9 14 1375 1380 I-treatment
transplant 15 25 1381 1391 I-treatment

No 0 2 1392 1394 O
prior 3 8 1395 1400 B-treatment
radiotherapy 9 21 1401 1413 I-treatment
to 22 24 1414 1416 O
the 25 28 1417 1420 O
region 29 35 1421 1427 O
of 36 38 1428 1430 O
the 39 42 1431 1434 O
study 43 48 1435 1440 O
cancer 49 55 1441 1447 B-cancer
that 56 60 1448 1452 O
would 61 66 1453 1458 O
result 67 73 1459 1465 O
in 74 76 1466 1468 O
overlap 77 84 1469 1476 O
of 85 87 1477 1479 O
radiation 88 97 1480 1489 B-treatment
therapy 98 105 1490 1497 I-treatment
fields 106 112 1498 1504 O

No 0 2 1505 1507 O
prior 3 8 1508 1513 B-treatment
systemic 9 17 1514 1522 I-treatment
chemotherapy 18 30 1523 1535 I-treatment
or 31 33 1536 1538 O
radiation 34 43 1539 1548 B-treatment
therapy 44 51 1549 1556 I-treatment
for 52 55 1557 1560 O
salivary 56 64 1561 1569 B-cancer
gland 65 70 1570 1575 I-cancer
malignancy 71 81 1576 1586 I-cancer

No 0 2 1587 1589 O
prior 3 8 1590 1595 B-treatment
systemic 9 17 1596 1604 I-treatment
chemotherapy 18 30 1605 1617 I-treatment
or 31 33 1618 1620 O
radiation 34 43 1621 1630 B-treatment
therapy 44 51 1631 1638 I-treatment
for 52 55 1639 1642 O
salivary 56 64 1643 1651 B-cancer
gland 65 70 1652 1657 I-cancer
malignancy 71 81 1658 1668 I-cancer
( 82 83 1669 1670 O
prior 83 88 1670 1675 B-treatment
chemotherapy 89 101 1676 1688 I-treatment
for 102 105 1689 1692 O
a 106 107 1693 1694 O
different 108 117 1695 1704 O
cancer 118 124 1705 1711 B-cancer
is 125 127 1712 1714 O
allowable 128 137 1715 1724 O
) 137 138 1724 1725 O

No 0 2 1726 1728 O
significant 3 14 1729 1740 O
pre 15 18 1741 1744 O
- 18 19 1744 1745 O
existing 19 27 1745 1753 O
hearing 28 35 1754 1761 B-chronic_disease
loss 36 40 1762 1766 I-chronic_disease
, 40 41 1766 1767 O
as 42 44 1768 1770 O
defined 45 52 1771 1778 O
by 53 55 1779 1781 O
the 56 59 1782 1785 O
patient 60 67 1786 1793 O
or 68 70 1794 1796 O
treating 71 79 1797 1805 O
physician 80 89 1806 1815 O

Not 0 3 1816 1819 B-pregnancy
pregnant 4 12 1820 1828 I-pregnancy
or 13 15 1829 1831 O
nursing 16 23 1832 1839 O

Pathologic 0 10 1840 1850 B-cancer
stage 11 16 1851 1856 I-cancer
T3 17 19 1857 1859 I-cancer
- 19 20 1859 1860 I-cancer
4 20 21 1860 1861 I-cancer
or 22 24 1862 1864 O
N1 25 27 1865 1867 O
- 27 28 1867 1868 O
3 28 29 1868 1869 O
or 30 32 1870 1872 O
T1 33 35 1873 1875 O
- 35 36 1875 1876 O
2 36 37 1876 1877 O
, 37 38 1877 1878 O
N0 39 41 1879 1881 O
with 42 46 1882 1886 O
a 47 48 1887 1888 O
close 49 54 1889 1894 O
( 55 56 1895 1896 O
≤ 56 57 1896 1897 O
1 58 59 1898 1899 B-upper_bound
mm 59 61 1899 1901 I-upper_bound
) 61 62 1901 1902 O
or 63 65 1903 1905 O
microscopically 66 81 1906 1921 O
positive 82 90 1922 1930 O
surgical 91 99 1931 1939 B-treatment
margin 100 106 1940 1946 O

Platelets 0 9 1947 1956 B-clinical_variable
≥ 10 11 1957 1958 O
100,000 12 19 1959 1966 B-lower_bound
cells 20 25 1967 1972 I-lower_bound
/ 25 26 1972 1973 I-lower_bound
mm^3 26 30 1973 1977 I-lower_bound

Pre 0 3 1978 1981 O
- 3 4 1981 1982 O
existing 4 12 1982 1990 O
≥ 13 14 1991 1992 O
grade 15 20 1993 1998 B-lower_bound
2 21 22 1999 2000 I-lower_bound
neuropathy 23 33 2001 2011 B-chronic_disease

Protocol 0 8 2012 2020 O
- 8 9 2020 2021 O
specific 9 17 2021 2029 O
requirements 18 30 2030 2042 O
may 31 34 2043 2046 O
also 35 39 2047 2051 O
exclude 40 47 2052 2059 O
immunocompromised 48 65 2060 2077 B-chronic_disease
patients 66 74 2078 2086 O

Radiologic 0 10 2087 2097 O
confirmation 11 23 2098 2110 O
of 24 26 2111 2113 O
the 27 30 2114 2117 O
absence 31 38 2118 2125 O
of 39 41 2126 2128 O
hematogenous 42 54 2129 2141 B-cancer
metastasis 55 65 2142 2152 I-cancer
within 66 72 2153 2159 O
12 73 75 2160 2162 B-upper_bound
weeks 76 81 2163 2168 I-upper_bound
prior 82 87 2169 2174 I-upper_bound
to 88 90 2175 2177 O
registration 91 103 2178 2190 O
; 103 104 2190 2191 O
at 105 107 2192 2194 O
a 108 109 2195 2196 O
minimum 110 117 2197 2204 O
, 117 118 2204 2205 O
contrast 119 127 2206 2214 O
CT 128 130 2215 2217 B-treatment
imaging 131 138 2218 2225 I-treatment
of 139 141 2226 2228 O
the 142 145 2229 2232 O
chest 146 151 2233 2238 O
is 152 154 2239 2241 O
required 155 163 2242 2250 O
( 164 165 2251 2252 O
PET 165 168 2252 2255 B-treatment
/ 168 169 2255 2256 I-treatment
CT 169 171 2256 2258 I-treatment
is 172 174 2259 2261 O
acceptable 175 185 2262 2272 O
) 185 186 2272 2273 O

Serum 0 5 2274 2279 B-clinical_variable
creatinine 6 16 2280 2290 I-clinical_variable
< 17 18 2291 2292 O
2.0 19 22 2293 2296 B-upper_bound
mg 23 25 2297 2299 I-upper_bound
/ 25 26 2299 2300 I-upper_bound
dL 26 28 2300 2302 I-upper_bound

Surgical 0 8 2303 2311 B-treatment
resection 9 18 2312 2321 I-treatment
with 19 23 2322 2326 O
curative 24 32 2327 2335 O
intent 33 39 2336 2342 O
within 40 46 2343 2349 O
8 47 48 2350 2351 B-upper_bound
weeks 49 54 2352 2357 I-upper_bound
prior 55 60 2358 2363 I-upper_bound
to 61 63 2364 2366 O
registration 64 76 2367 2379 O

Total 0 5 2380 2385 B-clinical_variable
bilirubin 6 15 2386 2395 I-clinical_variable
< 16 17 2396 2397 O
2 18 19 2398 2399 B-upper_bound
x 20 21 2400 2401 I-upper_bound
the 22 25 2402 2405 I-upper_bound
institutional 26 39 2406 2419 I-upper_bound
upper 40 45 2420 2425 I-upper_bound
limit 46 51 2426 2431 I-upper_bound
of 52 54 2432 2434 I-upper_bound
normal 55 61 2435 2441 I-upper_bound
( 62 63 2442 2443 I-upper_bound
ULN 63 66 2443 2446 I-upper_bound
) 66 67 2446 2447 I-upper_bound

Transmural 0 10 2448 2458 B-chronic_disease
myocardial 11 21 2459 2469 I-chronic_disease
infarction 22 32 2470 2480 I-chronic_disease
within 33 39 2481 2487 O
the 40 43 2488 2491 O
last 44 48 2492 2496 B-upper_bound
6 49 50 2497 2498 I-upper_bound
months 51 57 2499 2505 I-upper_bound

Unstable 0 8 2506 2514 B-chronic_disease
angina 9 15 2515 2521 I-chronic_disease
and/or 16 22 2522 2528 O
congestive 23 33 2529 2539 B-chronic_disease
heart 34 39 2540 2545 I-chronic_disease
failure 40 47 2546 2553 I-chronic_disease
requiring 48 57 2554 2563 O
hospitalization 58 73 2564 2579 B-treatment
within 74 80 2580 2586 O
the 81 84 2587 2590 O
last 85 89 2591 2595 B-upper_bound
6 90 91 2596 2597 I-upper_bound
months 92 98 2598 2604 I-upper_bound

Women 0 5 2605 2610 B-gender
of 6 8 2611 2613 O
childbearing 9 21 2614 2626 O
potential 22 31 2627 2636 O
and 32 35 2637 2640 O
male 36 40 2641 2645 B-gender
participants 41 53 2646 2658 I-gender
who 54 57 2659 2662 O
are 58 61 2663 2666 O
sexually 62 70 2667 2675 O
active 71 77 2676 2682 O
must 78 82 2683 2687 O
practice 83 91 2688 2696 B-contraception_consent
adequate 92 100 2697 2705 I-contraception_consent
contraception 101 114 2706 2719 I-contraception_consent
during 115 121 2720 2726 O
treatment 122 131 2727 2736 B-treatment
and 132 135 2737 2740 O
for 136 139 2741 2744 O
6 140 141 2745 2746 B-upper_bound
weeks 142 147 2747 2752 I-upper_bound
following 148 157 2753 2762 O
treatment 158 167 2763 2772 O

Zubrod 0 6 2773 2779 B-clinical_variable
performance 7 18 2780 2791 I-clinical_variable
status 19 25 2792 2798 I-clinical_variable
0 26 27 2799 2800 B-lower_bound
- 27 28 2800 2801 O
1 28 29 2801 2802 B-upper_bound

patients 0 8 2803 2811 O
must 9 13 2812 2816 O
be 14 16 2817 2819 O
free 17 21 2820 2824 O
of 22 24 2825 2827 O
distant 25 32 2828 2835 B-cancer
metastases 33 43 2836 2846 I-cancer
based 44 49 2847 2852 O
upon 50 54 2853 2857 O
the 55 58 2858 2861 O
following 59 68 2862 2871 O
minimum 69 76 2872 2879 O
diagnostic 77 87 2880 2890 O
workup 88 94 2891 2897 O

